Viet Nam Buys 30 Million AstraZeneca COVID-19 Vaccines

The COVID-19 vaccine developed by the UK's AstraZeneca and the University of Oxford has been approved for use in Viet Nam's urgent situation, according to Minister of Health Nguyen Thanh Long. This is the first COVID-19 vaccine approved by Viet Nam.

Minister Long stated in a government press release issued on January 30, 2021, AstraZeneca pledged to supply 30 million vaccine doses for Viet Nam in 2021.

Vaccine research and development in Viet Nam has also launched.

The first stage of human trials of the home-grown vaccine, Nanocovax, began on December 17, 2020, while the second vaccine candidate, Covivac, launched on January 21, 2021.

After nearly two-months without reporting local COVID-19 cases, Viet Nam has confirmed an ongoing outbreak with 28 new cases of COVID-19 on January 30th, raising the patient tally to 1,767.